Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Kapp

Showing results (51-60 of 124) with videos related to

Pageof 13
Sort By:
Experimental Dermatology|August 21, 2008
Intracutaneous injection of the macrophage-activating lipopeptide-2 (MALP-2) which accelerates wound healing in mice--a phase I trial in 12 patientsMargarete Niebuhr, Peter F Mühlradt, Miriam Wittmann, et al.
Acta Dermato-Venereologica|April 3, 2013
Management of childhood urticaria: current knowledge and practical recommendationsHelene Pite, Bettina Wedi, Luís Miguel Borrego, et al.
Melanoma Research|May 10, 2014
Is there a therapeutic benefit of complete lymph node dissection in melanoma patients with low tumor burden in the sentinel node?Imke Satzger, Andre Meier, Antonia Zapf, et al.
Allergy|July 21, 2021
Identification of novel biomarkers to distinguish bradykinin-mediated angioedema from mast cell-/histamine-mediated angioedemaGesa Bindke, Manuela Gehring, Dorothea Wieczorek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 27, 2013
Serious skin toxicity with the combination of BRAF inhibitors and radiotherapyImke Satzger, Annette Degen, Hiba Asper, et al.
The Journal of Investigative Dermatology|March 20, 2015
IL-31 Induces Chemotaxis, Calcium Mobilization, Release of Reactive Oxygen Species, and CCL26 in Eosinophils, Which Are Capable to Release IL-31Nikola Kunsleben, Urda Rüdrich, Manuela Gehring, et al.
International Journal of Cancer|August 8, 2007
Autoimmunity as a prognostic factor in melanoma patients treated with adjuvant low-dose interferon alphaImke Satzger, Andre Meier, Florian Schenck, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 23, 2007
Therapeutic use of erythropoietin in dermatooncologyImke Satzger, Florian Schenck, Felicitas Thol, et al.
The American Journal of Surgical Pathology|August 2, 2007
Prognostic significance of isolated HMB45 or Melan A positive cells in Melanoma sentinel lymph nodesImke Satzger, Bernward Völker, Andre Meier, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|May 5, 2021
[In appreciation of Professor Hans F. Merk : Editorial board and publisher bid farewell to the long-serving editor of the journal Der Hautarzt]Julie Kind, Michael Jünger, Alexander Kapp, et al.
Pageof 13

Showing results (51-60 of 124) with videos related to

Sort By:
Pageof 13
Experimental Dermatology|August 21, 2008
Intracutaneous injection of the macrophage-activating lipopeptide-2 (MALP-2) which accelerates wound healing in mice--a phase I trial in 12 patientsMargarete Niebuhr, Peter F Mühlradt, Miriam Wittmann, et al.
Acta Dermato-Venereologica|April 3, 2013
Management of childhood urticaria: current knowledge and practical recommendationsHelene Pite, Bettina Wedi, Luís Miguel Borrego, et al.
Melanoma Research|May 10, 2014
Is there a therapeutic benefit of complete lymph node dissection in melanoma patients with low tumor burden in the sentinel node?Imke Satzger, Andre Meier, Antonia Zapf, et al.
Allergy|July 21, 2021
Identification of novel biomarkers to distinguish bradykinin-mediated angioedema from mast cell-/histamine-mediated angioedemaGesa Bindke, Manuela Gehring, Dorothea Wieczorek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 27, 2013
Serious skin toxicity with the combination of BRAF inhibitors and radiotherapyImke Satzger, Annette Degen, Hiba Asper, et al.
The Journal of Investigative Dermatology|March 20, 2015
IL-31 Induces Chemotaxis, Calcium Mobilization, Release of Reactive Oxygen Species, and CCL26 in Eosinophils, Which Are Capable to Release IL-31Nikola Kunsleben, Urda Rüdrich, Manuela Gehring, et al.
International Journal of Cancer|August 8, 2007
Autoimmunity as a prognostic factor in melanoma patients treated with adjuvant low-dose interferon alphaImke Satzger, Andre Meier, Florian Schenck, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 23, 2007
Therapeutic use of erythropoietin in dermatooncologyImke Satzger, Florian Schenck, Felicitas Thol, et al.
The American Journal of Surgical Pathology|August 2, 2007
Prognostic significance of isolated HMB45 or Melan A positive cells in Melanoma sentinel lymph nodesImke Satzger, Bernward Völker, Andre Meier, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|May 5, 2021
[In appreciation of Professor Hans F. Merk : Editorial board and publisher bid farewell to the long-serving editor of the journal Der Hautarzt]Julie Kind, Michael Jünger, Alexander Kapp, et al.
Pageof 13